In glioma, HELLS regulates the proliferation of stem cell-like glioblastoma stem cells by interacting with key oncogenic TFs E2F3 and MYC; targeted the inhibition of HELLS and prolonged survival in mice and improved the prognosis of patients with increased HELLS expression (17). The gene discussed is E2F3; the disease is central nervous system cancer.